🇺🇸 Shensong Yangxin capsule in United States

16 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 16

Most-reported reactions

1. Asthenia — 2 reports (12.5%)
2. Conjunctival Hyperaemia — 2 reports (12.5%)
3. Conjunctival Ulcer — 2 reports (12.5%)
4. Hepatic Function Abnormal — 2 reports (12.5%)
5. Rash — 2 reports (12.5%)
6. Skin Exfoliation — 2 reports (12.5%)
7. Acquired Epidermolysis Bullosa — 1 report (6.25%)
8. Condition Aggravated — 1 report (6.25%)
9. Dysphagia — 1 report (6.25%)
10. Eating Disorder — 1 report (6.25%)

Source database →

Frequently asked questions

Is Shensong Yangxin capsule approved in United States?

Shensong Yangxin capsule does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Shensong Yangxin capsule in United States?

kejiang Cao is the originator. The local marketing authorisation holder may differ — check the official source linked above.